In the advanced/metastatic GC, TAMs can create an immunosuppressive microenvironment by inhibiting T-cell response, promoting regulatory T-cell (Tregs) accumulation, and producing anti-inflammatory cytokines like interleukin-10 (IL-10) and TGF-β. The gene discussed is IL10; the disease is gastric cancer.